Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2025. Below is a summary of business progress in 2025, financial performance for the year and the financial outlook ...

This article discusses the application of Sections 280G and 4999 of the Internal Revenue Code and related treasury regulations (“IRC” or “Code”), ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...

Slay the Spire 2 may still be in early access, but wow... It's already incredible. Here's our preview of the game so far.

Men and partners are important contributors to the health of future generations, yet their own preconception health and wellbeing remain secondary considerations in research, practice, and policy.

Washington — President Trump and his allies are pushing Senate Republicans to pass an elections-related bill known as the SAVE America Act, which Democrats warn could disenfranchise millions of ...

Day One Biopharmaceuticals stock remains a "Strong Buy." Learn more about its outlook, surging revenue, and ADC pipeline catalysts.

The HITS technology in the G Pro X2 Superstrike is revolutionary and probably the future of gaming mice, but isn't a priority for all gamers.

'One Battle After Another' took home six Academy Awards, including Best Picture ...